Aurinia Pharmaceuticals Inc (AUPH) Financial Statements (2024 and earlier)

Company Profile

Business Address #140, 14315 - 118 AVENUE
EDMONTON, AB T5L 4S6
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments389,306465,821398,329
Cash and cash equivalents94,088231,643272,350
Short-term investments295,218234,178125,979
Receivables   1,018
Inventory, net of allowances, customer advances and progress billings24,75219,32613,927
Inventory24,75219,32613,927
Prepaid expense13,58012,5066,153
Other current assets1,334796 
Other undisclosed current assets13,56714,875 
Total current assets:442,539513,324419,427
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization   
Operating lease, right-of-use asset4,9075,3835,489
Property, plant and equipment3,6504,4184,786
Long-term investments and receivables  24,380
Long-term investments  24,380
Intangible assets, net (including goodwill)6,4258,4049,332
Intangible assets, net (excluding goodwill)6,4258,4049,332
Other noncurrent assets13,33911,838247
Total noncurrent assets:28,32130,04344,234
TOTAL ASSETS:470,860543,367463,661
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:39,99034,94724,797
Employee-related liabilities18,24211,307
Accounts payable3,0873,8792,635
Accrued liabilities22,9338,44310,855
Other undisclosed accounts payable and accrued liabilities13,9704,383 
Deferred revenue3,148  
Debt   
Other liabilities2,0334,6406,118
Other undisclosed current liabilities9361,0591,082
Total current liabilities:46,10740,64631,997
Noncurrent Liabilities
Long-term debt and lease obligation 7,6807,619
Finance lease, liability   
Liabilities, other than long-term debt19,31815,9501,589
Other liabilities12,16615,9501,589
Operating lease, liability7,1527,6807,619
Other undisclosed noncurrent liabilities   14,706
Total noncurrent liabilities:19,31823,63023,914
Total liabilities:65,42564,27655,911
Equity
Equity, attributable to parent, including:405,435479,091407,750
Additional paid in capital85,48959,01439,383
Accumulated other comprehensive loss(1,061)(852)(805)
Accumulated deficit(864,302)(756,122)(575,156)
Other undisclosed equity, attributable to parent1,185,3091,177,051944,328
Total equity:405,435479,091407,750
TOTAL LIABILITIES AND EQUITY:470,860543,367463,661

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Revenues134,03045,60550,118
Cost of revenue(5,664)(1,091) 
Cost of goods and services sold(3,646)  
Gross profit:128,36644,51450,118
Operating expenses(44,988)(53,237)(154,408)
Other operating income (expense), net1,523(574) 
Other undisclosed operating loss(196,371)(171,438) 
Operating loss:(111,470)(180,735)(104,290)
Interest and debt expense   
Loss from continuing operations before equity method investments, income taxes:(111,470)(180,735)(104,290)
Other undisclosed income from continuing operations before income taxes5,1185291,516
Loss from continuing operations before income taxes:(106,352)(180,206)(102,774)
Income tax expense (benefit)(1,828)(760)94
Loss from continuing operations:(108,180)(180,966)(102,680)
Loss before gain (loss) on sale of properties:(180,966)(102,680)
Net loss available to common stockholders, diluted:(108,180)(180,966)(102,680)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
Net loss:(108,180)(180,966)(102,680)
Other comprehensive income (loss)(209)(47) 
Comprehensive loss:(108,389)(181,013)(102,680)
Other undisclosed comprehensive income, net of tax, attributable to parent   
Comprehensive loss, net of tax, attributable to parent:(108,389)(181,013)(102,680)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: